Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer

Table 1 Patient Characteristics

Characteristic	Categories	Number	Percent (%)
Vital Status	Expired	82	48.2
	Censored¹	88	51.8
Prior Treatment	Previously treated disease	134	78.8
History	Newly diagnosed	36	21.2
Stage at Diagnosis	Stage I	25	14.7
	Stage II	15	8.8
	Stage III	106	62.4
	Stage IV	14	8.2
	Missing	10	5.9
Age at Presentation	Mean	53.4
	Median	54.2
	Range	23.1 - 82.5
Baseline CA125 at study entry	0-35 U/ml	31	18.2
	>35 U/ml	139	81.8

ISSN: 1757-2215